Xiangxue Pharmaceutical Free Cash Flow Generation Index
Xiangxue Pharmaceutical free cash flow generation index. Xiangxue Pharmaceutical (300147) has a Free Cash Flow Generation Index of 0.92x as of September 2025. Free cash flow of CN¥69.90 Million represents 1% of operating cash flow (CN¥75.64 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Xiangxue Pharmaceutical (2007–2025)
Free cash flow generation index of Xiangxue Pharmaceutical from 2007 to 2025. Historical FCF Generation Index trend for Xiangxue Pharmaceutical across 19 annual periods. See Xiangxue Pharmaceutical free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Xiangxue Pharmaceutical Free Cash Flow Generation Index by Year (2007–2025)
Xiangxue Pharmaceutical free cash flow generation index by year from 2007 to 2025. Year-by-year Free Cash Flow Generation Index for Xiangxue Pharmaceutical. For the full cash flow conversion analysis, see 300147 operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.85x | CN¥118.12 Million | CN¥139.63 Million | CN¥21.51 Million | ▲ +190.1% |
| 2024 | -0.94x | CN¥-17.07 Million | CN¥18.17 Million | CN¥35.24 Million | ▼ -219.3% |
| 2023 | 0.79x | CN¥207.41 Million | CN¥263.44 Million | CN¥56.03 Million | ▲ +228.0% |
| 2022 | -0.62x | CN¥-139.89 Million | CN¥227.38 Million | CN¥367.27 Million | ▲ +48.1% |
| 2021 | -1.18x | CN¥-305.18 Million | CN¥257.56 Million | CN¥562.74 Million | ▲ +32.3% |
| 2020 | -1.75x | CN¥-450.24 Million | CN¥257.18 Million | CN¥707.42 Million | ▲ +74.9% |
| 2019 | -6.96x | CN¥-578.07 Million | CN¥83.02 Million | CN¥661.09 Million | ▼ -57.2% |
| 2018 | -4.43x | CN¥-404.23 Million | CN¥91.24 Million | CN¥495.46 Million | ▲ +27.4% |
| 2017 | -6.10x | CN¥-668.33 Million | CN¥109.53 Million | CN¥777.87 Million | ▲ +31.5% |
| 2016 | -8.91x | CN¥-1.77 Billion | CN¥198.48 Million | CN¥1.97 Billion | ▼ -1116.4% |
| 2015 | -0.73x | CN¥-117.06 Million | CN¥159.89 Million | CN¥276.95 Million | ▼ -54.9% |
| 2014 | -0.47x | CN¥-78.27 Million | CN¥165.58 Million | CN¥243.85 Million | ▼ -1681.0% |
| 2013 | 0.03x | CN¥9.82 Million | CN¥328.37 Million | CN¥318.55 Million | ▲ +101.2% |
| 2012 | -2.52x | CN¥-299.22 Million | CN¥118.91 Million | CN¥418.12 Million | ▲ +63.0% |
| 2011 | -6.81x | CN¥-201.13 Million | CN¥29.55 Million | CN¥230.69 Million | ▼ -2614.0% |
| 2010 | -0.25x | CN¥-11.40 Million | CN¥45.47 Million | CN¥56.87 Million | ▼ -73.6% |
| 2009 | -0.14x | CN¥-6.67 Million | CN¥46.19 Million | CN¥52.86 Million | ▲ +90.2% |
| 2008 | -1.47x | CN¥-81.99 Million | CN¥55.72 Million | CN¥137.71 Million | ▼ -2924.4% |
| 2007 | -0.05x | CN¥-6.71 Million | CN¥138.02 Million | CN¥144.73 Million | — |